Unicycive Therapeutics, Inc.

NASDAQ:UNCY

0.4347 (USD) • At close October 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 41.7848.939.70114.34518.81824.3320.4557.0110.57313.6216.57918.0110.0010.14700.0630.001-0.0150.015-0.025
Short Term Investments 000000000000000000.0300.05
Cash and Short Term Investments 41.7848.939.70114.34518.81824.3320.4557.0110.57313.6216.57918.0110.0010.14700.0630.0010.0150.0150.025
Net Receivables 00000000000000000000
Inventory 00000000000000000000
Other Current Assets 2.2742.7463.6980.6820.320.3190.1590.0690.1040.1370.1261.7130.010.0840.0040.1560.02700.0040
Total Current Assets 44.05451.67613.39918.56921.9326.1842.6449.96212.5615.46418.41119.7820.9130.5130.2040.2190.0280.0150.0190.025
Non-Current Assets:
Property, Plant & Equipment, Net 0.6470.7090.7920.8730.9531.0180.1740.2150.2560.2960.333000000000
Goodwill 00000000000000000000
Intangible Assets 00000000000000000000
Goodwill and Intangible Assets 00000000000000000000
Long Term Investments 00000000000000000000
Tax Assets 00000000000000000000
Other Non-Current Assets -0-000-0.953-1.018-0.174-0.215-0.2560000.8640.272000-0.0150-0.025
Total Non-Current Assets 0.6470.7090.7920.8730.9531.0180.1740.2150.2560.2960.33300.8640.272000-0.0150-0.025
Total Assets 44.70152.38514.19119.44222.88327.2022.81810.17712.81615.7618.74419.7820.9130.5130.2040.2190.02800.0190
Liabilities & Equity:
Current Liabilities:
Account Payables 1.4721.240.8210.990.4460.610.8462.2160.6990.5620.7130.0430.3340.160.1840.2160.42700.3220
Short Term Debt 0.360.3430.3450.3140.3030.2760.2010.1650.2080.1820.180.1094.1233.4852.5141.7730.76200.460
Tax Payables 00000000000000000000
Deferred Revenue 0.0010.20802.531.689000000000000000
Other Current Liabilities 11.25328.49116.36811.62212.98115.0842.2373.1411.9271.6581.2120.6330.6580.270.1770.0910.12300.1210
Total Current Liabilities 13.08630.28217.53415.45615.41915.973.2845.5222.8342.4022.1050.7855.1153.9152.8752.081.31200.9030
Non-Current Liabilities:
Long Term Debt 46.18746.1870.4660.5520.6340.71500.0290.0720.1140.155000000000
Deferred Revenue Non-Current 00000000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000000
Other Non-Current Liabilities 0.2740.37200001.0470000000000000
Total Non-Current Liabilities 46.46146.5590.4660.5520.6340.7151.0470.0290.0720.1140.155000000000
Total Liabilities 59.54776.8411816.00816.05316.6853.2845.5512.9062.5162.260.7855.1153.9152.8752.081.31200.9030
Equity:
Preferred Stock 46.18746.18700.04426.20225.59900000000000000
Common Stock 0.0430.0370.0350.0350.0150.0150.0150.0150.0150.0150.0150.0150.0090.0090.0090.0370.03700.0360
Retained Earnings -75.649-85.504-64.541-56.743-52.41-48.572-33.997-28.669-23.112-19.476-15.939-13.187-7.986-6.886-5.922-5.042-4.340-3.6580
Accumulated Other Comprehensive Income/Loss -46.187-46.2240-0.044-26.2020000000-00000-0.8840-1.206
Other Total Stockholders Equity 60.7661.04860.69760.14259.22533.47533.51633.2833.00732.70532.40832.1693.7753.4753.2423.144302.7380
Total Shareholders Equity -14.846-24.456-3.8093.4346.8310.517-0.4664.6269.9113.24416.48418.997-4.202-3.402-2.671-1.861-1.303-0.884-0.884-1.206
Total Equity -14.846-24.456-3.8093.4346.8310.517-0.4664.6269.9113.24416.48418.997-4.202-3.402-2.671-1.861-1.303-0.884-0.884-1.206
Total Liabilities & Shareholders Equity 44.70152.38514.19119.44222.88327.2022.81810.17712.81615.7618.74419.7820.9130.5130.2040.2190.009-0.8840.019-1.206